top of page
IPST_Logo-removebg-preview.png

Scientific Direction

IPS Therapeutique Inc.

The scientific directors at IPST are likely the first people you’ll speak with.

Together, you’ll identify the challenges ahead, propose models and study designs and assemble a solution to allow the development program to move forward elegantly.

PTP_9820-Annie-Bouchard.jpg

Annie Bouchard, M.Sc

Annie’s specialty is cardiac and vascular surgery. Since 2000, she has assisted IPST clients in designing studies and models, providing vital input on the pros and cons of surgical induction methods in small animals.​

Andrey_Lozhkin_002-scaled.jpg

Andrey Lozhkin, Ph.D​

Andrey joined IPST in 2022, adding an immune bias onto his vast experience in heart failure.

Andrey’s encyclopedic knowledge of in vitro and in vivo experimentation is especially useful with IPST clients tackling complex inflammatory diseases and syndromes.​

16744E0D-7A67-41EA-B1FB-779F0FA96B84.JPG

Charles-E. Laurent, Ph.D​

An experienced cardiovascular pharmacologist, Charles introduced in vivo experiments at IPST in 2008, and initiated the PAH program a few years later. His understanding of the challenges of drug development allow him to position projects strategically for maximal impact.​

PTP_9883-Dany-Salvail-e1741379688409.jpg

Dan Salvail, Ph.D​

A cardiac electrophysiologist and passionate thoracic scientist, Dan communicates. A lot.

He designs studies, interprets the data and views datasets into regulatory context. His failing memory is the stuff of legend, as is his fearless enthusiasm. ​

bottom of page